Terms of Use

Effective April 30, 2026. These Terms are between you and Rework AS, trading as Genosight.

Legal entity: Rework AS, Norwegian organization number 927 255 812, registered address c/o Sebastian Oltedal Thorp, Vestveien 5B, 1450 Nesoddtangen, Norway.

1. Agreement

These Terms of Use govern your access to and use of Genosight, including the website, application, onboarding flow, DNA upload, reports, chat, billing, subscriptions, credit packs, and related services. By creating an account, accepting the informed consent, or using the service, you agree to these Terms.

The Privacy Policy and Informed Consent are incorporated into these Terms.

2. Eligibility

• You must be at least 18 years old.
• You must have legal capacity to enter into these Terms.
• You may upload only your own DNA data or DNA data you are legally authorized to provide with explicit consent from the person the data concerns.
• You may not use Genosight where doing so would violate applicable law.

3. The service

Genosight helps users explore consumer raw DNA data in context. The service may parse uploaded genotype files, derive findings, generate topical reports, provide findings chat, and maintain account, billing, and credit records.

The service changes over time. We may add, remove, rename, modify, or limit features, reports, credit costs, plans, providers, models, supported file types, and workflows. We will provide notice where a change materially affects paid access or sensitive-data processing.

3a. Intended use and regulatory classification

Intended purpose. Genosight is intended solely as an educational, informational, and lifestyle service for adults curious about their own genome. The intended purpose is general information and personal interest. Reports are designed to help users learn about variants present in their consumer-grade genetic data and the published research literature associated with those variants — they are not designed, intended, marketed, or provided as medical, clinical, diagnostic, predictive, prognostic, screening, monitoring, or treatment-decision tools.

Genosight is not a medical device, an in-vitro diagnostic medical device, or software as a medical device within the meaning of:

• EU Regulation (EU) 2017/746 on in-vitro diagnostic medical devices (IVDR), as adopted into Norwegian law via the EEA Agreement;
• EU Regulation (EU) 2017/745 on medical devices (MDR), as adopted into Norwegian law via the EEA Agreement;
• the UK Medical Devices Regulations 2002, as amended;
• the United States Federal Food, Drug, and Cosmetic Act, including the FDA medical-device framework and the General Wellness policy;
• the IMDRF Software as a Medical Device (SaMD) definition.

The product fits within the lifestyle, well-being, and educational information category referenced in IVDR Recital 8 and equivalent guidance. Genosight does not perform a clinical examination of human specimens for the purpose of providing information on a physiological or pathological state, predisposition to disease, treatment-response prediction, or monitoring of therapeutic measures (IVDR Article 2(2)) — even where users upload genetic data, the service interprets that data only as educational variant-association information, never as diagnostic, predictive, or clinical-decision output.

Users who require clinical genetic testing, genetic counselling, or any form of medical advice must obtain those services through a qualified clinician or accredited clinical laboratory. Genosight is not a substitute for any of these.

What this means in practice. Reports describe what published research has associated with variants present in your uploaded data, in plain language. Reports never tell you to start, stop, or change a medication, supplement, dose, screening interval, treatment, or other clinical action. Reports always defer medically-relevant findings to your healthcare provider for interpretation in your full clinical context.

4. Medical, genetic, and safety disclaimers

• Genosight is not a healthcare provider. We do not practice medicine, diagnose, treat, prescribe, order tests, or provide emergency services.
• Genosight is not a clinical diagnostic test. It is not a substitute for clinician-ordered genetic testing, clinical laboratory confirmation, genetic counseling, medical screening, or professional medical advice.
• Do not make medical decisions based on Genosight alone.Do not start, stop, or change medication, dosage, supplements, treatment, screening, or reproductive decisions without consulting a qualified professional.
• Pharmacogenomics requires professional review.Drug-response findings can support discussions with your prescriber or pharmacist, but they do not determine whether any medication is safe, effective, or appropriate for you.
• Consumer DNA files have limitations. Raw files may be incomplete or inaccurate and may not include clinically important variants. A negative or absent finding does not rule out disease risk, carrier status, medication-response concerns, or hereditary risk. Serious findings require clinical confirmation.
• AI can be wrong. AI-generated text may omit context, overstate evidence, understate uncertainty, or generate an inaccurate response.

5. User responsibilities

• Provide accurate information where accuracy matters.
• Keep your account credentials secure.
• Review reports and chat outputs critically.
• Consult qualified professionals for medical decisions.
• Do not upload unlawful, unauthorized, malicious, or infringing data.
• Do not attempt to bypass credit checks, usage limits, rate limits, or security controls.
• Do not scrape, reverse engineer, resell, or misuse the service.

6. Your data and license to process

You retain your rights in data you submit. You grant Genosight a limited, worldwide, non-exclusive license to host, store, copy, process, analyze, transform, display, and transmit your data only as needed to (a) provide, secure, and support the service for you, (b) comply with law, and (c) enforce these Terms.

Service-improvement uses are bounded. The license above does not authorise Genosight to use your genetic data, health-profile data, raw DNA file, individual report content, or chat history for general service improvement, model training, or analytics in identifiable form. Improvement uses of those categories are limited to:

• Anonymised, aggregate analytics that cannot reasonably be re-linked to you (for example, aggregate counts of how many users encountered an engine error on a given chip version), used to monitor reliability and operating quality; and
• Separately opted-in research or AI-improvement participation, where you have explicitly ticked an additional consent in account settings and we have described the specific use to you. This is opt-in only, not part of the core consent, and can be withdrawn at any time without affecting your access to the service.

We do not use your genetic or health-profile data to train AI provider models. AI providers (currently Anthropic) are contractually committed not to train on Genosight API traffic; this posture is documented in our subprocessor register and our Security Model and only changes if we negotiate it explicitly and update those documents. Changing the posture would require renewed consent under the Informed Consent versioning process.

You represent that you have the rights and authority necessary to provide any data you upload or enter. You are responsible for any harm caused by uploading data without proper authority.

7. AI processing

Report generation and findings chat use AI providers. Genosight sends limited structured context to those providers, not your raw DNA file, legal name, email address, or exact date of birth. You acknowledge that AI outputs are probabilistic and may be incorrect.

8. Credits, subscriptions, and billing

Genosight uses credits to meter paid actions. New users may receive a free credit grant. Reports and findings-chat messages consume credits according to the prices shown in the app. Plans and credit packs may change, but changes will not reduce credits already posted to your account except where required to correct abuse, fraud, chargebacks, refunds, mistaken grants, or technical errors.

• Monthly and yearly subscriptions renew automatically unless cancelled before the renewal date. Recurring subscription credits are granted according to the plan in effect at the time of billing.
• Lifetime access is a one-time purchase that grants ongoing access subject to a published fair-use review policy:
  • A weekly credit allowance applies on an ongoing basis (the exact figure is shown in your account billing page).
  • Lifetime accounts whose 30-day credit consumption exceeds approximately five times the weekly allowance may be paused and surfaced to a manual fair-use review. The review checks for shared-credential / multi-person use, automated scraping, or other patterns inconsistent with a single individual's personal use.
  • Reviews are typically completed within five business days and resolved by either resuming the account or contacting the user at contact@genosight.ai to discuss appropriate continued access. Genuine personal use is never penalised, even at high volume; the review filter exists to catch credential-sharing and automated abuse.
  • If a review concludes the account has been used in a way the lifetime tier is not designed for (e.g. shared between multiple individuals), Genosight will, depending on severity, either set continued usage to a per-month cap, propose conversion to a different plan, or — only in clear-abuse cases — terminate the lifetime entitlement with a pro-rated refund.
• Credit packs are one-time purchases that add the stated number of credits to your account after successful payment.
• Checkout, invoices, cards, tax, refunds, and payment disputes are handled through Stripe. All payments are processed by Stripe under their terms at stripe.com/legal. Genosight does not store or process card data. Refund requests should be sent to contact@genosight.ai with order details — Stripe makes the final determination on disputed payments and chargebacks under their own dispute resolution process.

Except where mandatory consumer law provides otherwise, fees are non-refundable once credits have been granted, reports generated, or chat usage consumed. If you believe a charge, credit grant, or credit deduction is wrong, contact support promptly.

Norwegian and EU consumers — 14-day right of withdrawal. Under the Norwegian Consumer Contracts Act § 7 (and equivalent national implementations of EU Directive 2011/83/EU on Consumer Rights), consumers domiciled in Norway and the EU/EEA have a statutory 14-day right of withdrawal from distance-purchased digital services. To exercise this right, email contact@genosight.ai within 14 days of the original purchase with your name, account email, and order details. Refunds are processed within 14 days of confirmation.

Express request for immediate digital-content delivery (Norway Consumer Contracts Act § 22(n) / EU Consumer Rights Directive Art. 16(m)). Genosight delivers digital content (reports, chat responses, credits) to the user's account immediately upon successful payment. As part of the checkout flow, Genosight presents an unchecked acknowledgement with the following text, which the user must affirmatively tick to complete the purchase:

"I expressly request that Genosight begin delivery of digital content (reports, chat responses, credit grants) immediately upon payment, before the 14-day withdrawal period ends. I acknowledge that I lose my right of withdrawal for any digital content that has already been delivered, generated, or consumed once delivery begins. I retain the withdrawal right for any unconsumed credits or undelivered content."

Tick records (timestamp, IP, version of the acknowledgement text, email) are retained per Privacy Policy § 9 retention rules. The same acknowledgement text is repeated in the purchase-confirmation email Genosight sends to the user immediately after payment. If the acknowledgement is not ticked, the purchase cannot complete; the user can complete a purchase later or contact contact@genosight.ai to discuss alternatives.

Withdrawal scope after the acknowledgement. Once the acknowledgement is ticked and digital content is delivered, the 14-day withdrawal right under Norwegian and EU consumer law no longer applies to the delivered or consumed portion: credits already spent on a generated report, a generated report itself, or chat messages already exchanged. The withdrawal right continues to apply to any unconsumed credits or undelivered subscription periods that have not yet been used. Refund requests for unconsumed portions go to contact@genosight.ai.

9. Cancellations

You can manage or cancel recurring subscriptions through the billing page or customer portal where available. Cancellation stops future renewals; it does not automatically refund past charges. Your current access continues until the end of the paid billing period unless otherwise stated in the app or required by law.

10. Prohibited uses

You may not use Genosight to:

• provide medical diagnosis or treatment to another person;
• make insurance, employment, lending, housing, or eligibility decisions;
• conduct surveillance, law-enforcement analysis, or forensic matching;
• identify or profile another person without consent;
• train competing models or services from Genosight outputs without permission;
• attack, overload, probe, or interfere with the service;
• violate any law, third-party right, or contractual obligation.

11. Law-enforcement and third-party database use

Genosight does not voluntarily provide genetic data, health profile data, reports, or chat history for law-enforcement database searches, forensic matching, insurance underwriting, employment screening, or data-broker resale. We may disclose information if required by valid legal process or applicable law, and where legally permitted we will seek to narrow the request and notify the affected user. Legal-demand statistics are published on the Transparency Report.

12. Intellectual property

Genosight and its software, design, prompts, workflows, databases, curation, branding, and documentation are owned by Genosight or its licensors. Subject to these Terms, Genosight grants you a limited, revocable, non-transferable, non-exclusive license to use the service for your personal, lawful purposes.

Reports generated for your account may be used by you for personal review and discussions with healthcare professionals, provided you do not remove safety disclaimers or misrepresent the output as clinical advice or a validated diagnostic result.

13. Availability and suspension

We aim to keep the service reliable, but it may be unavailable due to maintenance, model-provider issues, infrastructure issues, security events, or circumstances outside our control. We may suspend or restrict accounts to protect users, security, legal compliance, payment integrity, or service availability.

14. Third-party services

Genosight depends on third-party services, including DNA providers from which you obtain raw data, cloud infrastructure, AI providers, payment processors, email providers, and other vendors. We are not responsible for third-party products, terms, availability, accuracy, or security except as required by applicable law.

15. Disclaimers

The service is provided on an "as is" and "as available" basis. To the fullest extent permitted by law, Genosight disclaims warranties of accuracy, completeness, fitness for a particular purpose, non-infringement, uninterrupted availability, and error-free operation. Nothing in these Terms excludes warranties, remedies, or rights that cannot be excluded under mandatory consumer law.

16. Limitation of liability

To the fullest extent permitted by law, Genosight will not be liable for indirect, incidental, special, consequential, exemplary, or punitive damages; lost profits; lost data; loss of goodwill; personal decisions made from non-clinical outputs; or third-party service failures. Genosight's aggregate liability for claims arising out of or relating to the service is limited to the greater of the amount you paid to Genosight in the three months before the event giving rise to the claim or USD 100.

This limitation does not limit liability for death or personal injury caused by negligence where such limitation is prohibited, fraud, intentional misconduct, gross negligence, or rights that cannot be limited under mandatory law.

17. Indemnity

To the extent permitted by law, you will indemnify and hold Genosight harmless from claims, losses, liabilities, damages, fines, penalties, costs, and expenses arising from your unauthorized upload or use of another person's data, unlawful use of the service, violation of these Terms, or infringement of third-party rights.

18. Changes to Terms

We may update these Terms. If changes are material, we will provide notice through the app, email, or another reasonable method. Continued use after the effective date means you accept the updated Terms. If the change materially affects processing of sensitive data, we will request renewed consent where required.

19. Governing law and disputes

These Terms are governed by the laws of Norway, without regard to conflict-of-law rules. Courts in Norway have jurisdiction, subject to any mandatory consumer rights that allow you to bring claims in your country of residence.

20. Contact

Legal, service, privacy, and security questions: contact@genosight.ai. Use a clear subject line such as "Legal notice", "Privacy request", or "Security report".